William Plovanic
Stock Analyst at Canaccord Genuity
(3.49)
# 883
Out of 4,876 analysts
131
Total ratings
44.44%
Success rate
5.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Initiates: Buy | $35 | $30.90 | +13.27% | 1 | Jun 17, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Hold | $115 → $101 | $91.45 | +10.44% | 3 | May 12, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $152 → $139 | $154.66 | -10.13% | 10 | May 2, 2025 | |
| DXCM DexCom | Maintains: Buy | $103 → $106 | $86.35 | +22.76% | 6 | May 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $58 → $59 | $18.93 | +211.67% | 4 | May 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $71 → $75 | $78.10 | -3.97% | 26 | Apr 25, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $23 → $18 | $5.82 | +209.28% | 8 | Apr 8, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 | $5.30 | +107.55% | 4 | Mar 28, 2025 | |
| ATRC AtriCure | Maintains: Buy | $66 → $52 | $32.30 | +60.99% | 11 | Mar 28, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $104 | $131.41 | -20.86% | 5 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $8 | $3.54 | +126.31% | 3 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $18.86 | +74.97% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $101 | $58.55 | +72.50% | 3 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $269 → $304 | $312.71 | -2.79% | 3 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $101 | $106.90 | -5.51% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $6.78 | +121.24% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $12 | $9.77 | +22.82% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $255.42 | +11.19% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $11.07 | +125.94% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $2.61 | +359.77% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $93.54 | -25.17% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $16.93 | +183.52% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $4.66 | +372.10% | 3 | Jul 25, 2023 |
Artivion
Jun 17, 2025
Initiates: Buy
Price Target: $35
Current: $30.90
Upside: +13.27%
Zimmer Biomet Holdings
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $91.45
Upside: +10.44%
iRhythm Technologies
May 2, 2025
Maintains: Buy
Price Target: $152 → $139
Current: $154.66
Upside: -10.13%
DexCom
May 2, 2025
Maintains: Buy
Price Target: $103 → $106
Current: $86.35
Upside: +22.76%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $58 → $59
Current: $18.93
Upside: +211.67%
Edwards Lifesciences
Apr 25, 2025
Maintains: Hold
Price Target: $71 → $75
Current: $78.10
Upside: -3.97%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $5.82
Upside: +209.28%
TriSalus Life Sciences
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $5.30
Upside: +107.55%
AtriCure
Mar 28, 2025
Maintains: Buy
Price Target: $66 → $52
Current: $32.30
Upside: +60.99%
TransMedics Group
Mar 11, 2025
Maintains: Buy
Price Target: $104
Current: $131.41
Upside: -20.86%
Mar 5, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $3.54
Upside: +126.31%
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $18.86
Upside: +74.97%
Jan 10, 2025
Maintains: Buy
Price Target: $92 → $101
Current: $58.55
Upside: +72.50%
Dec 9, 2024
Maintains: Buy
Price Target: $269 → $304
Current: $312.71
Upside: -2.79%
Dec 9, 2024
Maintains: Buy
Price Target: $98 → $101
Current: $106.90
Upside: -5.51%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $6.78
Upside: +121.24%
Oct 4, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $9.77
Upside: +22.82%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $255.42
Upside: +11.19%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $11.07
Upside: +125.94%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $2.61
Upside: +359.77%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $93.54
Upside: -25.17%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $16.93
Upside: +183.52%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $4.66
Upside: +372.10%